Funding received for the first discovery program

OncoArendi was successful in securing 1,6M in public financing in an joint application with the Institute of Biophysics and Biochemistry, Polish Academy of Sciences and the International Institute for Molecular and Cell Biology for a project entitled „New drug candidates for targeted therapy of multiple myeloma”.